ESTIMATED
03/14/2014
03/14/2014
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|
Nymox Pharmaceutical Corporation last posted its earnings results on Friday, March 14th, 2014. The company reported $-0.03 earnings per share for the quarter, topping analysts' consensus estimates of $-0.06 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Nymox Pharmaceutical Corporation has generated $0 earnings per share over the last year ($-0.0735 diluted earnings per share) and currently has a price-to-earnings ratio of -2.61. Nymox Pharmaceutical Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 2nd, 2023 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 08/14/2023 | Q2 2023 | -$0.01 | $0 | 05/12/2023 | Q1 2023 | -$0.02 | $0 | 05/02/2023 | Q4 2022 | -$0.05 | $0 | 11/14/2022 | Q3 2022 | -$0.02 | $0 | 08/15/2022 | Q2 2022 | $0.04 | $0 | 05/13/2022 | Q1 2022 | -$0.06 | $0 | 03/30/2022 | Q4 2021 | $0.00 | $0 | 11/12/2021 | Q3 2021 | -$0.04 | $0 | 08/13/2021 | Q2 2021 | -$0.05 | $0 | 05/14/2021 | Q1 2021 | -$0.03 | $0 | 03/29/2021 | Q4 2020 | $0.00 | $0 | 11/13/2020 | Q3 2020 | -$0.06 | $0 | 08/14/2020 | Q2 2020 | -$0.04 | $0 | 05/14/2020 | Q1 2020 | -$0.04 | $5,000 | 03/30/2020 | Q4 2019 | $0.00 | $26,000 | 11/13/2019 | Q3 2019 | -$0.04 | $39,000 | 08/14/2019 | Q2 2019 | -$0.08 | $20,000 | 05/15/2019 | Q1 2019 | -$0.04 | $30,000 | 03/29/2019 | Q4 2018 | $0.00 | $19,000 | 11/13/2018 | Q3 2018 | -$0.05 | $40,000 |
---|
A. Nymox Pharmaceutical Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 2nd, 2023 based off last year's report dates.
A. In the previous quarter, Nymox Pharmaceutical Corporation (NASDAQ:NYMX) reported $-0.03 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.06 by $0.03.
A. The conference call for Nymox Pharmaceutical Corporation's latest earnings report can be listened to online.
A. The conference call transcript for Nymox Pharmaceutical Corporation's latest earnings report can be read online.
A. Nymox Pharmaceutical Corporation (NASDAQ:NYMX) has a recorded net income of $0. Nymox Pharmaceutical Corporation has generated $-0.0735 earnings per share over the last four quarters.
A. Nymox Pharmaceutical Corporation (NASDAQ:NYMX) has a price-to-earnings ratio of -2.61 and price/earnings-to-growth ratio is -0.05.